Bioscience Animal Health PCLBKK:BIS +0.98%81 ROA % is 5.70% as of Mar. 2026, which is 9% above its 10-year median of 5.24. GuruFocus rates BKK:BIS with a GF Score™ of 81/100 and a GF Value™ of ฿2.87 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,993 Consumer Packaged Goods companies, Bioscience Animal Health PCL ranks worse than 52.13% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Bioscience Animal Health PCL's annualizedNet Income for the quarter that ended in Mar. 2026 was ฿70 Mil.
Bioscience Animal Health PCL's average Total Assets over the quarter that ended in Mar. 2026 was ฿1,231 Mil. Therefore, Bioscience Animal Health PCL's annualized ROA % for the quarter that ended in Mar. 2026 was 5.70%.
The historical rank and industry rank for Bioscience Animal Health PCL's ROA % or its related term are showing as below:
BKK:BIS'
s ROA % Range Over the Past 10 Years
Min: 1.11 Med: 5.24 Max: 8.35
Current: 3.01
During the past 9 years, Bioscience Animal Health PCL's highest ROA % was 8.35%. The lowest was 1.11%. And the median was 5.24%.
BKK:BIS's ROA % is ranked worse than 52.13% of 1993
companies
in the Consumer Packaged Goods industry
Industry Median: 3.29
vs BKK:BIS: 3.01
Bioscience Animal Health PCL (BKK:BIS) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Bioscience Animal Health PCL ROA % Related Terms
Bioscience Animal Health PCL ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Bioscience Animal Health PCL's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioscience Animal Health PCL ROA % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioscience Animal Health PCL's ROA % distribution charts can be found below:
* The bar in red indicates where Bioscience Animal Health PCL's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Bioscience Animal Health PCL (BKK:BIS) has a ROA % of 5.70% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Bioscience Animal Health PCL and its competitors. This is near median its historical median of 5.24. Over the past decade, Bioscience Animal Health PCL's ROA % has ranged from 1.11 to 8.35. According to the industry distribution chart, Bioscience Animal Health PCL ranks #1039 out of 1993 companies in the Consumer Packaged Goods industry, placing it in the top 52.1%.
Is Bioscience Animal Health PCL's ROA % too high?
Bioscience Animal Health PCL's current ROA % of 5.70% is near median its 10-year median of 5.24. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 8.35. The Consumer Packaged Goods industry median ROA % is 3.29. Bioscience Animal Health PCL's value of 5.70% is 73.3% above this industry median. Based on the distribution chart, Bioscience Animal Health PCL ranks #1039 out of 1993 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Bioscience Animal Health PCL has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioscience Animal Health PCL's ROA % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bioscience Animal Health PCL ranks #1039 out of 1993 companies for ROA %. This places Bioscience Animal Health PCL in the lower half of its industry. The industry median ROA % is 3.29. Bioscience Animal Health PCL's value of 5.70% is 73.3% above this benchmark. Historically, Bioscience Animal Health PCL's own ROA % has ranged from 1.11 to 8.35 over the past decade. While the company's 10-year median is 5.24 vs. the industry median of 3.29, Bioscience Animal Health PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Consumer Packaged Goods company?
The median ROA % among Consumer Packaged Goods companies is 3.29, based on 1,993 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioscience Animal Health PCL's current ROA % of 5.70% is 73.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Bioscience Animal Health PCL and its competitors. For the Consumer Packaged Goods industry, the median ROA % is 3.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioscience Animal Health PCL's current ROA % is 5.70%, which is near median its own 10-year median of 5.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioscience Animal Health PCL stock overvalued right now?
Based on GuruFocus' analysis, Bioscience Animal Health PCL (BKK:BIS) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿2.87, compared to a current price of ฿2.06 — trading 28.2% below its estimated fair value. The current ROA % is 5.70%, which is near median its 10-year median of 5.24 and 73.3% above the Consumer Packaged Goods industry median of 3.29. Bioscience Animal Health PCL's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Bioscience Animal Health PCL (BKK:BIS), the current ROA % is 5.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioscience Animal Health PCL (BKK:BIS) Overvalued in 2026?
Based on GuruFocus' analysis, Bioscience Animal Health PCL stock appears to be undervalued.
The current stock price of ฿2.06 is trading 28.2% below its estimated GF Value™ of ฿2.87.
GuruFocus considers Bioscience Animal Health PCL to be Modestly Undervalued.
Key valuation signals for BKK:BIS:
ROA %: 5.70% (near median its 10-year median of 5.24)
GF Value™: ฿2.87 vs. price of ฿2.06 (28.2% below fair value)
Industry Position: 73.3% above the Consumer Packaged Goods median (#1039 of 1993)
No single metric tells the full story. See the BKK:BIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioscience Animal Health PCL along with its subsidiaries is engaged in the manufacturing, import and distribution of pharmaceutical supplies, medical devices, equipment and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand, and also has presence in other countries.
81GF Score
Get the complete analysis for BKK:BIS
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BIS has been successfully added to your 
